Alpelisib, sold under the brand name Piqray among others, is a medication used to treat certain types of breast cancer. It is used together with fulvestrant. It is taken by mouth. It is marketed by Novartis. From Wikipedia
Her prognosis is estimated at three years following the NHS decision to decline sacral radiotherapy
